TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Merck Life Science Oy
Closing information (x1000 EUR)
| Closing information | 2016/12 | 2015/12 | 2014/12 |
| Turnover |
8,253
|
7,756
|
5,477 |
| Financial expenses |
1
|
1
|
4 |
| Earnings before taxes |
250
|
182
|
311 |
| Total assets |
2,080
|
1,863
|
1,724 |
| Current assets |
27
|
25
|
62 |
| Current liabilities |
713
|
695
|
700 |
| Equity capital |
1,366
|
1,167
|
1,023 |
| - share capital |
140
|
140
|
140 |
| Employees (average) | 8 | 7 |
Financial ratios
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Solvency |
65.7%
|
62.6%
|
59.3% |
| Turnover per employee | 1,032 | 782 | |
| Profit as a percentage of turnover |
3.0%
|
2.3%
|
5.7% |
| Return on assets (ROA) |
12.1%
|
9.8%
|
18.3% |
| Current ratio |
3.8%
|
3.6%
|
8.9% |
| Return on equity (ROE) |
18.3%
|
15.6%
|
30.4% |
| Change turnover |
497
|
2,279
|
264 |
| Change turnover % |
6%
|
42%
|
5% |
| Chg. No. of employees | -1 | ||
| Chg. No. of employees % | -13% |
Total value of public sale
| Fiscal year | 2016/12 | 2015/12 | 2014/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.